<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39411616</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Variables Associated With In-Hospital Lethality in COVID-19: A Prospective Cohort Study From Colombia.</ArticleTitle><Pagination><StartPage>e69368</StartPage><MedlinePgn>e69368</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e69368</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.69368</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The emergence of COVID-19 represents the most significant health crisis in recent history. Incidence and mortality rates depend on several factors. Many studies have focused on investigating which characteristics could be strongly related to higher mortality and lethality.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to analyze the variables associated with in-hospital mortality among patients admitted in a reference northeastern region of a Colombian institution.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An ambidirectional cohort, single-center study was carried out in a reference hospital in northeastern Colombia. All patients admitted to the Fundación Oftalmológica de Santander (FOSCAL) between March 2020 and September 2021, with COVID-19 real-time polymerase chain reaction (PCR) positive test, were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 3,028 patients were included, of whom 2,034 (67.8%) survived and 994 (32.8%) died during their hospital stay; 48.8% (1,479) of the patients were female. The most common comorbidities were hypertension (1,236 patients, 40.8%), obesity (body mass index (BMI) ≥ 30; 656 patients, 21.6%), and diabetes (618 patients, 20.4%). The average age of the surviving patients was 52.2 years, while for the deceased patients, it was 70.3 years. The variables that showed significant association with in-hospital mortality were as follows: male sex ≥ 45 years, dyspnea, oxygen saturation (SatO2) &lt; 85%, hypertension, chronic kidney disease (CKD), and a Charlson Comorbidity Index (CCI) score of &gt;1.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Male sex, age ≥ 45 years, dyspnea, SatO2 &lt; 85%, hypertension, CKD, and a CCI score of &gt;1 were associated with a higher risk of in-hospital mortality in COVID-19-infected patients.</AbstractText><CopyrightInformation>Copyright © 2024, Lora Mantilla et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lora Mantilla</LastName><ForeName>Alvaro J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cáceres Ramírez</LastName><ForeName>Catalina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riaño Duarte</LastName><ForeName>Andrea K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amaya Muñoz</LastName><ForeName>Maria C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayala-Gutierrez</LastName><ForeName>Maria C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villabona</LastName><ForeName>Silvia J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cala Duran</LastName><ForeName>Julian C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camacho López</LastName><ForeName>Paul Anthony</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez Laitton</LastName><ForeName>Edgar D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Research, Development, and Technological Innovation Department, Fundación Oftalmológica de Santander, Floridablanca, COL.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">colombia</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">lethality</Keyword><Keyword MajorTopicYN="N">sars cov-2</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Research Ethics Committee CEI-Fundación Oftalmológica de Santander (FOSCAL) issued approval 02895/2020. It is approved expediently and the approval is ratified. The Research and Ethics Committee of the Fundación Oftalmológica de Santander (FOSCAL) deems that the project meets all the required quality standards. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39411616</ArticleId><ArticleId IdType="pmc">PMC11473248</ArticleId><ArticleId IdType="doi">10.7759/cureus.69368</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 epidemiological update-15 July 2024.  [
Jul;
2024 
]. 2023. https://www.who.int/publications/m/item/covid-19-epidemiological-update-edition-169 https://www.who.int/publications/m/item/covid-19-epidemiological-update-edition-169</Citation></Reference><Reference><Citation>Characterization and pathophysiology of SARS-CoV-2, review of current literature. Forero Argüello H, Hernández Martínez A, Lobo Moncada D, Garcia Bohorquez DF, Fajardo Rivera JE. https://revistas.uis.edu.co/index.php/revistamedicasuis/article/view/12659 Médicas UIS. 2021;34:61–75.</Citation></Reference><Reference><Citation>Orús A. Cumulative number of coronavirus cases worldwide from January 22, 2020 to August 2, 2023. Coronavirus: Cumulative Global Number of Cases.  [
Jul;
2024 
]. 2023. https://es.statista.com/estadisticas/1104227/numero-acumulado-de-casos-de-coronavirus-covid-19-en-el-mundo-enero-marzo/  https://es.statista.com/estadisticas/1104227/numero-acumulado-de-casos-de-coronavirus-covid-19-en-el-mundo-enero-marzo/ </Citation></Reference><Reference><Citation>Instituto Nacional de Salud. Noticias: coronavirus.  [
Jul;
2024 
];https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx 2023 18:2024.</Citation></Reference><Reference><Citation>The determinants of COVID-19 morbidity and mortality across countries. Chang D, Chang X, He Y, Tan KJ. Sci Rep. 2022;12:5888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989117</ArticleId><ArticleId IdType="pubmed">35393471</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis of COVID-19 mortality and survival in Colombia: a prospective cohort study. Malagón-Rojas J, Ibáñez E, Parra B EL, Toloza-Perez YG, Álvarez S, Mercado M. Infectio. 2020;25:3.</Citation></Reference><Reference><Citation>Clinical characteristics and mortality associated with COVID-19 at high altitude: a cohort of 5161 patients in Bogotá, Colombia. Rodriguez Lima DR, Pinzón Rondón ÁM, Rubio Ramos C, et al. Int J Emerg Med. 2022;15:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9123834</ArticleId><ArticleId IdType="pubmed">35597911</ArticleId></ArticleIdList></Reference><Reference><Citation>General hospitalization and Intensive Care Unit-related factors of COVID-19 patients in northeastern Colombia: baseline characteristics of a cohort study. Cáceres Ramírez C, Lora Mantilla AJ, Parra Gómez LA, et al. Cureus. 2023;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10515459</ArticleId><ArticleId IdType="pubmed">37746500</ArticleId></ArticleIdList></Reference><Reference><Citation>LimeSurvey GmbH.  [
Jul;
2024 
];https://www.limesurvey.org/es 2020 18:2024.</Citation></Reference><Reference><Citation>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Charlson ME, Pompei P, Ales KL, et al. J Chronic Dis. 1987;5:373–383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Validation and adaptation of the Charlson Comorbidity Index using administrative data from the Colombian health system: retrospective cohort study. Oliveros H, Buitrago G. BMJ Open. 2022;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943719</ArticleId><ArticleId IdType="pubmed">35321892</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. Huang YQ, Gou R, Diao YS, et al. J Zhejiang Univ Sci B. 2014;15:58–66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3891119</ArticleId><ArticleId IdType="pubmed">24390745</ArticleId></ArticleIdList></Reference><Reference><Citation>Early routine biomarkers of SARS-CoV-2 morbidity and mortality: outcomes from an emergency section. Ceci FM, Fiore M, Gavaruzzi F, et al. Diagnostics (Basel) 2022;12:176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8774587</ArticleId><ArticleId IdType="pubmed">35054342</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictors of mortality in acute hospitalised COVID-19 pneumonia patients: a retrospective cohort study at two tertiary-level hospitals in Zambia. Banda J, Mweemba A, Bulaya T, et al.  http://www.samj.org.za/index.php/samj/article/view/13555. S Afr Med J. 2022;112:273–278.</Citation><ArticleIdList><ArticleId IdType="pubmed">35587806</ArticleId></ArticleIdList></Reference><Reference><Citation>Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan. Sarfaraz S, Shaikh Q, Saleem SG, Rahim A, Herekar FF, Junejo S, Hussain A. https://pubmed.ncbi.nlm.nih.gov/34043674/ PLoS One. 2021;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158897</ArticleId><ArticleId IdType="pubmed">34043674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Bellan M, Patti G, Hayden E, et al. Sci Rep. 2020;10:20731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692524</ArticleId><ArticleId IdType="pubmed">33244144</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors associated with clinical outcomes in 323 coronavirus disease 2019 (COVID-19) hospitalized patients in Wuhan, China. Hu L, Chen S, Fu Y, et al. Clin Infect Dis. 2020;16:2089–2098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197620</ArticleId><ArticleId IdType="pubmed">32361738</ArticleId></ArticleIdList></Reference><Reference><Citation>Smoking is associated with COVID-19 progression: a meta-analysis. Patanavanich R, Glantz SA. Nicotine Tob Res. 2020;22:1653–1656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239135</ArticleId><ArticleId IdType="pubmed">32399563</ArticleId></ArticleIdList></Reference><Reference><Citation>Obesity as a predictor for a poor prognosis of COVID-19: a systematic review. Tamara A, Tahapary DL. Diabetes Metab Syndr. 2020;14:655–659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217103</ArticleId><ArticleId IdType="pubmed">32438328</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortality-related risk factors of COVID- 19: a systematic review and meta-analysis of 42 studies and 423,117 patients. Dessie ZG, Zewotir T. BMC Infect Dis. 2021;21:855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Wang B, Li R, Lu Z, Huang Y. Aging (Albany NY) 2020;12:6049–6057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185114</ArticleId><ArticleId IdType="pubmed">32267833</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of Charlson comorbidity index on mortality from SARS‐CoV‐2 virus infection and a novel COVID‐19 mortality index: CoLACD. Varol Y, Hakoglu B, Kadri Cirak A, et al. Int J Clin Pract. 2021;19:2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744887</ArticleId><ArticleId IdType="pubmed">33237615</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaluation of the potential risk of mortality from SARS-CoV-2 infection in hospitalized patients according to the Charlson comorbidity index. Gutierrez-Camacho JR, Avila-Carrasco L, Murillo-Ruíz-Esparza A, et al. Healthcare (Basel) 2022;19:2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872141</ArticleId><ArticleId IdType="pubmed">35206976</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of sex and gender on COVID-19 outcomes in Europe. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Biol Sex Differ. 2020;11:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. Li LQ, Huang T, Wang YQ, et al. J Med Virol. 2020;92:577–583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228329</ArticleId><ArticleId IdType="pubmed">32162702</ArticleId></ArticleIdList></Reference><Reference><Citation>Gender differences in patients with COVID- 19: focus on severity and mortality. [ Jul; 2024 ];Jin JM, Bai P, He W, et al. Front Public Health. 2020 8:152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>